Last updated on November 2018

A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)


Brief description of study

Phase I Dose Escalation: Primary objective is to determine the MTD and the recommended dose for Phase I Extension. Secondary objective is to investigate the safety, pharmacokinetics and efficacy of BI 836858 in combination with decitabine Phase I Extension: Primary objective is to collect additional data on safety, pharmacokinetics and efficacy and to define the Recommended Phase II Dose (RP2D) of BI 836858 in combination with decitabine.

Phase II: Primary objective is to investigate efficacy, safety and pharmacokinetics of BI 836858 in combination with decitabine compared to decitabine monotherapy.

Clinical Study Identifier: NCT02632721

Contact Investigators or Research Sites near you

Start Over

Boehringer Ingelheim Call Center

Mayo Clinic Cancer Center
Jacksonville, FL United States
  Connect »

Boehringer Ingelheim Call Center

Kommunalunternehmen Klinikum Augsburg
Augsburg, Germany
  Connect »

Boehringer Ingelheim Call Center

Universit tsklinikum Carl Gustav Carus Dresden
Dresden, Germany
  Connect »

Boehringer Ingelheim Call Center

Universit tsklinikum Jena
Jena, Germany
  Connect »

Boehringer Ingelheim Call Center

Northwell Health
Lake Success, NY United States
  Connect »

Boehringer Ingelheim Call Center

The Ohio State University Wexner Medical Center
Columbus, OH United States
  Connect »

Boehringer Ingelheim Call Center

Hospital Vall d'Hebron
Barcelona, Spain
  Connect »

Boehringer Ingelheim Call Center

Hospital Cl nic de Barcelona
Barcelona, Spain
  Connect »

Boehringer Ingelheim Call Center

Hospital Polit cnic La Fe
Valencia, Spain
  Connect »

Boehringer Ingelheim Call Center

A.O. Spedali Civili di Brescia
Brescia, Italy
  Connect »

Boehringer Ingelheim Call Center

Vivantes Netzwerk f r Gesundheit GmbH
Berlin, Germany
  Connect »

Boehringer Ingelheim Call Center

Emory University
Atlanta, GA United States
  Connect »

Boehringer Ingelheim Call Center

Northwestern University
Chicago, IL United States
  Connect »

Boehringer Ingelheim Call Center

Universit tsklinikum Hamburg-Eppendorf
Hamburg, Germany
  Connect »

Boehringer Ingelheim Call Center

Universit tsklinikum M nster
Münster, Germany
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.